{"result": "(\"entity\"<|>ECHA<|>ORGANIZATION<|>ECHA refers to a condition related to chronic liver disease and hepatic encephalopathy, focusing on nutritional support and management strategies.)\n##\n(\"entity\"<|>AACR<|>ORGANIZATION<|>AACR stands for branched-chain amino acids, which are used in nutritional supplementation for patients with hepatic encephalopathy.)\n##\n(\"entity\"<|>HEPATOPATÍA CRÓNICA<|>EVENT<|>Hepatopatía crónica refers to chronic liver disease, which requires specific nutritional support and management.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional support provided through enteral feeding, especially important for patients unable to ingest food orally.)\n##\n(\"entity\"<|>VITAMINA D<|>PERSON<|>Vitamin D is a fat-soluble vitamin that is often deficient in patients with chronic liver disease and is monitored for supplementation.)\n##\n(\"relationship\"<|>ECHA<|>AACR<|>ECHA utilizes AACR as a therapeutic option for managing hepatic encephalopathy<|>7)\n##\n(\"relationship\"<|>HEPATOPATÍA CRÓNICA<|>NUTRICIÓN ENTERAL<|>Nutritional support through enteral feeding is crucial for patients with chronic liver disease<|>8)\n##\n(\"relationship\"<|>ECHA<|>HEPATOPATÍA CRÓNICA<|>ECHA is a condition that arises from chronic liver disease, necessitating specific nutritional strategies<|>6)\n##\n(\"relationship\"<|>VITAMINA D<|>HEPATOPATÍA CRÓNICA<|>Vitamin D deficiency is common in patients with chronic liver disease and requires monitoring<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ivo\n                                                                                                                               Este tipo de sondas no aumentan el riesgo de san-\n\nun desencadenante oculto de encefalopatía (sangrado,\nno   cumplimiento        terapéutico,      abuso    de   sustancias,     lento o intermitente no es una contraindicación para la\netc.). La suplementación con AACR puede contribuir a                     nutrición enteral.\nla mejoría de la encefalopatía 136, aunque no han sido                      Una opción aceptable es proveer la nutrición enteral\ncomparados frente a otras medidas antiencefalopatía.                     durante la noche, permitiendo la ingesta oral durante\nSustituir las proteínas de origen animal por las de ori-                 el día. No se recomienda la colocación de gastrosto-\ngen vegetal, más ricas en AACR y acompañadas de fibra                    mías o yeyunostomías en pacientes con ascitis, por el\nprebiótica, podría tener utilidad118.                                    riesgo de complicaciones tales como peritonitis o fístu-\n   Los aminoácidos ramificados podrían constituir una                    la de líquido ascítico149.\nopción terapéutica basada en la fisiopatología. Isoleu-                     Se deben evitar períodos prolongados sin soporte\ncina y valina son sustratos anapleuróticos, que pueden                   nutricional, dada la dificultad en mantener y reponer el\nretirar amonio, mediador de la sarcopenia, y por tanto                   estado nutricional.\nrevertir la misma137. En pacientes sarcopénicos, la su-                     En pacientes con retención de líquidos la fórmula en-\nplementación con AACR 12 g al día, mejora la supervi-                    teral será preferiblemente energética (1,5 kcal/ml)150.\nvencia106.                                                                  Es importante descartar la presencia de malabsor-\n                                                                         ción, sobre todo en pacientes con colestasis y etilismo\n10.4.    Suplementos vitamínicos y minerales                             con posible insuficiencia pancreática. De ser así, habrá\n                                                                         que considerar el uso de fórmulas oligoméricas, aceite\n   Los pacientes con ECHA tienen riesgo de múltiples                     MCT y suplementación con enzimas pancreáticas.\ndeficiencias de micronutrientes, como se ha menciona-                       Hay estudios con resultados contradictorios sobre el\ndo anteriormente.                                                        papel de la nutrición enteral en pacientes cirróticos, y\n   La deficiencia de vitaminas liposolubles puede pre-                   se requiere mayor investigación115.\nsentarse en pacientes con esteatorrea por colestasis o                      Si el paciente no es capaz de ingerir alimentos por\ndeficiencia de sales biliares y en pacientes con etilis-                 boca por un bajo nivel de conciencia, como puede\nmo138, aunque pueden estar presentes también en pa-                      ocurrir durante los episodios de encefalopatía, se debe\ncientes sin colestasis139. Se recomienda monitorizar ni-                 iniciar nutrición enteral a través de sonda nasogástrica.\nveles   de   vitaminas      liposolubles,     y   suplementar       las  Incluso pacientes con encefalopatía episódica no ob-\ndeficiencias. El más frecuente es el de vitamina D, como                 tienen beneficio de la restricción proteica transitoria, y\nse ha referido anteriormente, presente hasta en un 90%                   pueden recibir aporte proteico de 1,2 a 1,5 g/kg135.\n---\n                                           Tema 16.     Soporte nutricional en la hepatopatía crónica y trasplante hepático                279\n\n\n\n   La mayoría de las fórmulas estándar ya contienen                            mificados, comercializadas como tratamiento de la\nuna proporción considerable de AACR, hasta un 25%.                             encefalopatía hepática, no son equilibradas en su con-\nLas fórmulas enriquecidas en AACR llegan al 35 y 41%.                          tenido en nutrientes, y no se recomiendan para ser\nNo hay evidencia suficiente de que estas fórmulas re-                          usadas solas ni como única fuente de nitrógeno en una\nsulten superiores a las estándar en cuanto a balance                           solución de nutrición parenteral. Se recomienda el uso\nnitrogenado,       síntesis   de    proteínas     y  encefalopatía,            de soluciones de aminoácidos estándar para la mayoría\naunque hay estudios que documentan una disminu-                                de pacientes con EHCA.\nción de eventos (muerte, frecuencia de hospitalización\ny duración de la misma)151. Su coste es mayor y su pa-                           La glucosa y los lípidos deberían aportarse en una\n                                                                               proporción de 65-35 a 50-50% de las calorías no pro-\nlatabilidad es pobre. En niños podrían resultar útiles152.                     teicas.\nSe requieren\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}